| 1714 |
1502: Histone deacetylase inhibition |
1504: p21 (CDKN1A) expression, increase |
Jan 21, 2018 |
Jul 25, 2018 |
None
|
| 1715 |
1502: Histone deacetylase inhibition |
1505: Cell cycle, disrupted |
Jan 21, 2018 |
Jul 28, 2021 |
1 AOP
|
| 1716 |
1502: Histone deacetylase inhibition |
1262: Apoptosis |
Jan 21, 2018 |
Jul 1, 2021 |
1 AOP
|
| 1717 |
1502: Histone deacetylase inhibition |
1506: Testicular atrophy |
Jan 21, 2018 |
Jul 28, 2021 |
1 AOP
|
| 1802 |
1502: Histone deacetylase inhibition |
1557: Reduced neural crest cell migration |
Dec 20, 2018 |
Dec 20, 2018 |
1 AOP
|
| 1805 |
1502: Histone deacetylase inhibition |
1558: Reduced collagen production |
Dec 20, 2018 |
Dec 20, 2018 |
1 AOP
|
| 2010 |
1502: Histone deacetylase inhibition |
1515: Spermatocyte depletion |
Dec 11, 2019 |
Jul 1, 2021 |
1 AOP
|
| 2699 |
1502: Histone deacetylase inhibition |
1561: Neural tube defects |
Jul 19, 2022 |
Jul 19, 2022 |
1 AOP
|
| 3328 |
2252: Formation of HLA-DQ2/8-gluten complexes |
272: Activation/Proliferation, T-cells |
Aug 13, 2024 |
Aug 13, 2024 |
None
|
| 3338 |
2252: Formation of HLA-DQ2/8-gluten complexes |
2260: Activation of gluten-reactive CD4+ T cells |
Sep 13, 2024 |
Sep 13, 2024 |
None
|
| 3383 |
2252: Formation of HLA-DQ2/8-gluten complexes |
2275: Co-localization of gluten reactive adaptive T-cells with APC |
Nov 12, 2024 |
Apr 8, 2025 |
1 AOP
|
| 2326 |
1853: Hyperactivation of ACE/Ang-II/AT1R axis |
1752: Increased AngII |
Apr 10, 2021 |
Apr 10, 2021 |
1 AOP
|
| 2521 |
1853: Hyperactivation of ACE/Ang-II/AT1R axis |
1535: Heart failure |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2762 |
1868: Hyperinflammation |
1748: Increase, the risk of acute respiratory failure |
Sep 1, 2022 |
Sep 1, 2022 |
None
|
| 3429 |
2289: RyR2 hyperphosphorylation |
389: Increased, Intracellular Calcium overload |
Nov 22, 2024 |
Nov 22, 2024 |
1 AOP
|
| 158 |
142: Hyperplasia, Hyperplasia |
334: Promotion, Hepatocelluar carcinoma |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 462 |
415: Hyperplasia, Leydig cell |
406: decreased, Fertility |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1115 |
1078: Hyperplasia, Mammary gland |
1080: Increased, latency period |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1116 |
1078: Hyperplasia, Mammary gland |
1079: Increased, Adenomas/carcinomas (mammary) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1093 |
1052: Hyperplasia, ovarian epithelium |
1053: Promotion, ovarian adenomas |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1094 |
1051: Hyperplasia, ovarian stromal cells |
1054: Promotion, ovarian granular cell tumors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 755 |
763: hyperpolarisation, neuron |
764: N/A, Ataxia, paralysis, or hyperactivity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1566 |
763: hyperpolarisation, neuron |
1428: Analgesia |
Jun 8, 2017 |
Jun 8, 2017 |
1 AOP
|
| 1572 |
763: hyperpolarisation, neuron |
1432: Anti-depressant Activity |
Jun 23, 2017 |
Jun 23, 2017 |
1 AOP
|
| 1083 |
1043: Hypertrophy/hyperplasia, smooth muscle |
1044: Promotion, mesovarian leiomyomas |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|